# Humacyte, Inc. (HUMA)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/HUMA/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 901.0K | $ -54.42M | $ -47.44M | $ 66.18M | $ 31.26M |
| 2025 | $ 2.09M | $ -41.81M | $ -108.46M | $ 64.85M | $ 3.11M |
| 2024 | $ 7.60M | $ -156.30M | $ -104.79M | $ 16.54M | $ -52.67M |
| 2023 | $ 0 | $ -119.78M | $ -81.73M | $ 57.51M | $ 13.55M |
| 2022 | $ 1.75M | $ -13.37M | $ -80.63M | $ 50.07M | $ 116.93M |
| 2021 | $ 1.50M | $ -31.47M | $ -96.77M | $ 51.18M | $ 122.17M |
| 2020 | $ 1.90M | $ -84.75M | $ -71.19M | $ 28.86M | $ 70.67M |
| 2019 | N/A | N/A | N/A | $ 28.72M | $ 132.20M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 2.12 |
| Liabilities / Eq | 3.42 |
| Current Ratio | 6.21 |

## Other views

- [Metrics](https://sponda.capital/en/HUMA.md)
- [Charts](https://sponda.capital/en/HUMA/charts.md)
- [Compare](https://sponda.capital/en/HUMA/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.